The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+T Cells Are Important in Control of SARS-CoV Infection
Open accessAbstract
We characterized the cellular immune response to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in 12- to 14-month-old BALB/c mice, a model that mimics features of the human disease. Following intranasal administration, the virus replicated in the lungs, with peak titers on day 2 postinfection. Enhanced production of cytokines (tumor necrosis factor alpha [TNF-α] and interleukin-6 [IL-6]) and chemokines (CXCL10, CCL2, CCL3, and CCL5) correlated with migration of NK cells, macrophages, and plasmacytoid dendritic cells (pDC) into the lungs. By day 7, histopathologic evidence of pneumonitis was seen in the lungs when viral clearance occurred. At this time, a second wave of enhanced production of cytokines (TNF-α, IL-6, gamma interferon [IFN-γ], IL-2, and IL-5), chemokines (CXCL9, CXCL10, CCL2, CCL3, and CCL5), and receptors (CXCR3, CCR2, and CCR5), was detected in the lungs, associated with an influx of T lymphocytes. Depletion of CD8+T cells at the time of infection did not affect viral replication or clearance. However, depletion of CD4+T cells resulted in an enhanced immune-mediated interstitial pneumonitis and delayed clearance of SARS-CoV from the lungs, which was associated with reduced neutralizing antibody and cytokine production and reduced pulmonary recruitment of lymphocytes. Innate defense mechanisms are able to control SARS-CoV infection in the absence of CD4+and CD8+T cells and antibodies. Our findings provide new insights into the pathogenesis of SARS, demonstrating the important role of CD4+but not CD8+T cells in primary SARS-CoV infection in this model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Monocyte-Mediated Defense Against Microbial Pathogens
Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090326 · Cited by 1,123
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Re-emergence of fatal human influenza A subtype H5N1 disease
Peiris, J., Yu, W., Leung, C., Cheung, C., Ng, W., Nicholls, J., Ng, T., Chan, K., Lai, S., Lim, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15595-5 · Cited by 812 · cited 1×
“Elevation of IL-6 and IL-8 during the acute phase of disease and persistent expression of CCL2/ MCP-1, CXCL9/MIG, and CXCL10/IP-10 in both acute and fatal cases were consistently detected in the blood of SARS patients (25, 26, 34, 43, 51).”
BackgroundTraggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · cited 1×
“Virusspecific neutralizing Abs reduce viral load, protect against weight loss, and reduce histopathology in animal models (42, 47, 48).”
BackgroundSelf-citationAn interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679
CHAN‐YEUNG, M., & XU, R. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00518.x · Cited by 577
Wong, R. S. M., Wu, A., To, K. F., Lee, N., Lam, C. W. K., Wong, C. K., Chan, P. K. S., Ng, M. H. L., Yu, L. M., Hui, D. S., et al. (2003) · BMJ · doi:10.1136/bmj.326.7403.1358 · Cited by 561
Immunopathogenesis of coronavirus infections: implications for SARS
Dandekar, A. A., & Perlman, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1732 · Cited by 499
T Cell Responses to Whole SARS Coronavirus in Humans
Li, C. K.-F., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 497
Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S.-F., Wu, M. H. S., Chan, K.-H., Yuen, K.-Y., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447
Self-citationSubbarao, K., McAuliffe, J., Vogel, L., Fahle, G., Fischer, S., Tatti, K., Packard, M., Shieh, W.-J., Zaki, S., & Murphy, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 406
Self-citationControl of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
Cervantes-Barragan, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2007) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 397
Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00527-07 · Cited by 386 · cited 2×
“Although the role of type I interferons (IFNs) in the natural history of SARS is controversial (5, 9, 59), the innate defense system appears to be critical for controlling SARSCoV replication in mice (23, 41).”
BackgroundBender, B. S., Croghan, T., Zhang, L., & Small, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1143 · Cited by 381
Eichelberger, M., Allan, W., Zijlstra, M., Jaenisch, R., & Doherty, P. C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.875 · Cited by 366
Glass, W. G., Subbarao, K., Murphy, B., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 340
Self-citationCharacterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 323
Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters
Roberts, A., Vogel, L., Guarner, J., Hayes, N., Murphy, B., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.503-511.2005 · Cited by 285
Self-citationLi, T., Qiu, Z., Zhang, L., Han, Y., He, W., Liu, Z., Ma, X., Fan, H., Lu, W., Xie, J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381535 · Cited by 282
Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo.
Taylor, P. M., & Askonas, B. A. (1986) · PubMed · Cited by 259
He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., & Dwyer, D. E. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.014 · Cited by 258
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Berlin, A., Ross, D. J., Kunkel, S. L., Charo, I. F., & Strieter, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12214 · Cited by 255
Tang, N. L.-S., Chan, P. K.-S., Wong, C.-K., To, K.-F., Wu, A. K.-L., Sung, Y.-M., Hui, D. S.-C., Sung, J. J.-Y., & Lam, C. W.-K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.054460 · Cited by 232
CHIEN, J., HSUEH, P., CHENG, W., YU, C., & YANG, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00942.x · Cited by 225
Moskophidis, D., & Kioussis, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.223 · Cited by 212
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Sheahan, T., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207
Roberts, A., Paddock, C., Vogel, L., Butler, E., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 198
Self-citationCousens, L. P., Orange, J. S., & Biron, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5690 · Cited by 176
CD4 T cell responses to influenza infection
Brown, D. M., Román, E., & Swain, S. L. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.02.004 · Cited by 174
Clearance of an Influenza A Virus by CD4+T Cells Is Inefficient in the Absence of B Cells
Topham, D. J., & Doherty, P. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.882-885.1998 · Cited by 173
Zhang, B., Chan, Y. K., Lu, B., Diamond, M. S., & Klein, R. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2641 · Cited by 168
Tate, M. D., Brooks, A. G., & Reading, P. C. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-57 · Cited by 163
Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro
Yen, Y., Liao, F., Hsiao, C.-H., Kao, C., Chen, Y., & Wu‐Hsieh, B. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2684-2693.2006 · Cited by 147
Hogan, R. J., Gao, G., Rowe, T., Bell, P. L., Flieder, D. B., Paragas, J., Kobinger, G., Wivel, N. A., Crystal, R. G., Boyer, J. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11416-11421.2004 · Cited by 134
Wiley, J. A., Cerwenka, A., Harkema, J. R., Dutton, R. W., & Harmsen, A. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63950-8 · Cited by 121
Fujisawa, H. (2008) · Journal of Virology · doi:10.1128/jvi.01210-07 · Cited by 121
Epidemiological and genetic analysis of severe acute respiratory syndrome
Donnelly, C. A., Fisher, M. C., Fraser, C., Ghani, A. C., Riley, S., Ferguson, N. M., & Anderson, R. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01173-9 · Cited by 113
Ziegler, T. T., Matikainen, S., Rönkkö, E., Österlund, P., Sillanpää, M., Sirén, J., Fagerlund, R., Immonen, M., Melén, K., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13800-13805.2005 · Cited by 83
Roche, J. K., Keepers, T. R., Gross, L. K., Seaner, R. M., & Obrig, T. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060366 · Cited by 83
Mice Susceptible to SARS Coronavirus
Wentworth, D. E., Gillim-Ross, L., Espina, N. G., & Bernard, K. A. (2004) · Emerging infectious diseases · doi:10.3201/eid1007.031119 · Cited by 69
HUANG, J., CAO, Y., Du, J., Bu, X., MA, R., & Wu, C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.047 · Cited by 63
Yang, L., Peng, H., Zhu, Z., Li, G., Huang, Z., Zhao, Z., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2007) · Journal of General Virology · doi:10.1099/vir.0.82839-0 · Cited by 56
Gerhard, W., Haberman, A. M., Scherle, P., Taylor, A. H., Palladino, G., & Caton, A. J. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.364-372.1991 · Cited by 54
Baas, T., Roberts, A., Teal, T. H., Vogel, L., Chen, J., Tumpey, T. M., Katze, M. G., & Subbarao, K. (2008) · Journal of Virology · doi:10.1128/jvi.00489-08 · Cited by 54
Self-citationMatzer, S. P., Baumann, T., Lukacs, N. W., Röllinghoff, M., & Beuscher, H. U. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4635 · Cited by 48
Vogel, L., Roberts, A., Paddock, C. D., Genrich, G. L., Lamirande, E. W., Kapadia, S. U., Rose, J. K., Zaki, S. R., & Subbarao, K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.055 · Cited by 25
Self-citationChristensen, J. P., Bartholdy, C., Wodarz, D., & Thomsen, A. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3384 · Cited by 25
Cited by
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,946
Metadata
- Authors
- Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2010-02
- Volume
- 84
- Issue
- 3
- Pages
- 1289-1301
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2166221102
- Cited by
- 399
- References
- 54
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.